Fuan Pharmaceutical (300194.SZ): Bromhexine hydrochloride injection obtained drug registration certificate

Zhitong Finance App News, Fu'an Pharmaceutical (300194.SZ) issued an announcement. Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (hereinafter referred to as “Tianheng Pharmaceutical”), a wholly-owned subsidiary of the company, recently received a drug registration certificate issued by the State Drug Administration, involving the drug: “bromhexine hydrochloride injection”.

Bromhexine hydrochloride injection is suitable for patients with chronic bronchitis and other respiratory diseases such as asthma, bronchiectasis, silicosis, etc. with sticky phlegm that is difficult to cough up when oral administration is difficult. According to the data search platform of the State Drug Administration, up to now, a total of 30 companies (including Tianheng Pharmaceutical) have passed or are deemed to have passed the consistency evaluation.